Entity Addresses, Address Type [Axis] Business Contact [Member] Class of Stock [Axis] Series C Convertible Preferred Stock [Member] Equity Components [Axis] Mezzanine [Member] Preferred Stock [Member] Common Stock [Member] Additional Paid-in Capital [Member] Retained Earnings [Member] Series C Preferred Stock [Member] Collaborative Arrangement and Arrangement Other than Collaborative [Axis] Securities Purchase Agreement [Member] Warrant [Member] Title and Position [Axis] Employee [Member] Award Type [Axis] First Installment 36 Months [Member] First Installment 10 Months [Member] First Installment 22 Months [Member] Equity Option [Member] Exercise Price Range [Axis] Exercisable Prices Two [Member] Exercisable Prices Three [Member] Exercisable Prices Four [Member] Exercisable Prices Five [Member] December 9 2024 [Member] Exercisable Prices Six [Member] Antidilutive Securities [Axis] Share-Based Payment Arrangement, Option [Member] Long-Lived Asset, Class [Axis] Computer Equipment [Member] Machinery and Equipment [Member] Related and Nonrelated Parties [Axis] Investor [Member] Purchase Agreement [Member] Statistical Measurement [Axis] Minimum [Member] Maximum [Member] 2022 Incentive Plan [Member] Non-Qualified Stock Options [Member] 35 Months [Member] 36 Months [Member] Exercisable Prices One [Member] Exercisable Prices Seven [Member] Class of Warrant or Right [Axis] Warrant One [Member] Warrant Two [Member] Warrant Three [Member] Warrant Four [Member] Warrant Five [Member] Vesting [Axis] 35 Months Vesting [Member] 36 Months Vesting [Member] Research Agreement [Member] Option Indexed to Issuer's Equity, Type [Axis] Call Option [Member] Put Option [Member] Legal Entity [Axis] GHS Investments LLC [Member] Equity Financing Agreement [Member] Segments [Axis] Single Reportable Segment [Member] Subsequent Event Type [Axis] Subsequent Event [Member] Entity Addresses [Table] Entity Addresses [Line Items] Document Type Amendment Flag Amendment Description Document Registration Statement Document Annual Report Document Quarterly Report Document Transition Report Document Shell Company Report Document Shell Company Event Date Document Period Start Date Document Period End Date Document Fiscal Period Focus Document Fiscal Year Focus Current Fiscal Year End Date Entity File Number Entity Registrant Name Entity Central Index Key Entity Primary SIC Number Entity Tax Identification Number Entity Incorporation, State or Country Code Entity Address, Address Line One Entity Address, Address Line Two Entity Address, Address Line Three Entity Address, City or Town Entity Address, State or Province Entity Address, Country Entity Address, Postal Zip Code Country Region City Area Code Local Phone Number Extension Written Communications Soliciting Material Pre-commencement Tender Offer Pre-commencement Issuer Tender Offer Title of 12(b) Security No Trading Symbol Flag Trading Symbol Security Exchange Name Title of 12(g) Security Security Reporting Obligation Annual Information Form Audited Annual Financial Statements Entity Well-known Seasoned Issuer Entity Voluntary Filers Entity Current Reporting Status Entity Interactive Data Current Entity Filer Category Entity Small Business Entity Emerging Growth Company Elected Not To Use the Extended Transition Period Document Accounting Standard Other Reporting Standard Item Number Entity Shell Company Entity Public Float Entity Bankruptcy Proceedings, Reporting Current Entity Common Stock, Shares Outstanding Documents Incorporated by Reference [Text Block] Contact Personnel Name Statement [Table] Statement [Line Items] ASSETS Current assets: Cash Prepaid expenses and other current assets Total current assets Property and equipment: Machinery and equipment Less: accumulated depreciation Net property and equipment Other assets: Patents, net of amortization of $31,735 and $30,224, respectively Deposit Total other assets Total assets LIABILITIES, MEZZANINE AND STOCKHOLDERS’ EQUITY (DEFICIT) Current liabilities: Accounts payable and accrued liabilities Total current liabilities Commitments and contingencies Mezzanine: Series C Convertible Preferred Stock Stockholders’ equity (deficit): Preferred stock, $0.0001 par value; 10,000,000 authorized shares Common stock, value Additional paid in capital Accumulated deficit Total stockholders’ deficit Total liabilities, mezzanine and stockholders’ equity Patents, amortization Temporary equity, shares outstanding Temporary equity, redeemable value Preferred stock, par value Preferred stock, shares authorized Common stock, par value Common stock, shares authorized Common stock, shares issued Common stock, shares outstanding Income Statement [Abstract] Revenue: Operating expenses: Selling and marketing expenses General and administrative expenses Research and development Depreciation and amortization Total operating expenses Loss from operations before other income (expense) Other income (expense): Interest income Other expenses Total other income (expense) Net income (loss) Basic earnings (loss) per share Diluted earnings (loss) per share Weighted average number of common shares outstanding, basic Weighted average number of common shares outstanding, diluted Balance Balance, shares Stock compensation cost Net loss Issuance of common shares for equity financing at cost Issuance of common shares for equity financing at cost, shares Issuance of common stock through equity financing Issuance of common stock through equity financing, shares Adjustment to mezzanine Adjustment to mezzanine, shares Balance Balance, shares Statement of Cash Flows [Abstract] CASH FLOWS FROM OPERATING ACTIVITIES: Net income (loss) Adjustments to reconcile net income (loss) to net cash provided by (used in) operating activities: Depreciation and amortization Non-cash stock compensation expense Changes in operating assets and liabilities: (Increase) Decrease in Changes in Assets Prepaid expenses and other current assets Increase (Decrease) in Changes in Liabilities Accounts payable and accrued liabilities Net cash provided by (used in) operating activities CASH FLOWS FROM INVESTING ACTIVITIES: CASH FLOWS FROM FINANCING ACTIVITIES: Common shares issued through an equity financing agreement Net cash provided by financing activities Net increase (decrease) in cash Cash, cash equivalents, and restricted cash - beginning of period Cash, cash equivalents, and restricted cash - end of period SUPPLEMENTAL DISCLOSURES OF CASH FLOW INFORMATION: Interest Income taxes Non-cash investing and financing activities: Issuance of common shares for equity financing Equity financing fees Adjustment to mezzanine Equity financing cost Accounting Policies [Abstract] ORGANIZATION AND NATURE OF BUSINESS SUMMARY OF SIGNIFICANT ACCOUNTING POLICIES Equity [Abstract] COMMON STOCK Share-Based Payment Arrangement [Abstract] STOCK OPTIONS AND WARRANTS Commitments and Contingencies Disclosure [Abstract] COMMITMENTS AND CONTINGENCIES Income Tax Disclosure [Abstract] INCOME TAXES Equity Financing Agreement EQUITY FINANCING AGREEMENT Segment Reporting [Abstract] SEGMENT INFORMATION Subsequent Events [Abstract] SUBSEQUENT EVENT PREFERRED STOCK Revenue Recognition Cash and Cash Equivalent Concentration Risk Use of Estimates Property and Equipment Intangible Assets Stock-Based Compensation Research and Development Net Earnings (Loss) per Share Calculations Fair Value of Financial Instruments Recently Issued Accounting Pronouncements Basis of Accounting Advertising and Marketing Segment Reporting SCHEDULE OF PROPERTY AND EQUIPMENT SCHEDULE OF INTANGIBLE ASSETS AMORTIZED OVER THEIR USEFUL LIVES SCHEDULE OF PATENT AMORTIZATION SCHEDULE OF NET EARNINGS PER SHARE SCHEDULE OF STOCK OPTIONS SCHEDULE OF WEIGHTED AVERAGE REMAINING CONTRACTUAL LIFE OF OPTIONS OUTSTANDING SCHEDULE OF WARRANTS ACTIVITY SCHEDULE OF WARRANTS OUTSTANDING SCHEDULE OF COMPONENTS OF INCOME TAX EXPENSE SCHEDULE OF NET DEFERRED TAX ASSETS SCHEDULE OF NET LOSS, OPERATING EXPENSES, OTHER INCOME, AND RECONCILIATION OF INCOME/LOSS TO ADJUSTED EBITDA Accumulated deficit Net loss Cash from operating activities SummaryOfSignificantAccountingPoliciesTable [Table] SummaryOfSignificantAccountingPoliciesLineItems [Line Items] Cash in excess of FDIC limits Depreciation expense Amortization expense Issuance of common shares to purchase warrants Purchase price of warrants Warrant exercise price Number of options, granted Options vesting Options vesting period Options granted outstanding Exercise price Option expiration term Option immediate exercisable Options vesting Exercisable period Options vested percentage Cancelled shares Expected to vest and exercisable shares Stock options, outstanding Stock options tranche description Stock option expiration date Share based compensation arrangement non vested, outstanding number Research and development costs Warrants outstanding Advertising and marketing costs Property, Plant, and Equipment [Table] Property, Plant, and Equipment [Line Items] Property and equipment, useful lives Patents Less accumulated amortization Intangible assets, useful lives Intangible assets Remainder of 2026 2027 2028 Thereafter Antidilutive Security, Excluded EPS Calculation [Table] Antidilutive Securities Excluded from Computation of Earnings Per Share [Line Items] Income (Loss) to common shareholders (Numerator) Basic weighted average number of common shares outstanding (Denominator) Diluted weighted average number of common shares outstanding (Denominator) Weighted average warrants to purchase common stock Stock, Class of Stock [Table] Class of Stock [Line Items] Temporary Equity, Shares Outstanding Temporary Equity, Carrying Amount, Attributable to Parent Temporary Equity, Par or Stated Value Per Share Preferred Stock, Convertible, Conversion Price Number of shares issued Sale of common stock value Shares price Finance cost Net proceeds Number of options, outstanding, beginning balance Weighted average exercise price, outstanding, beginning balance Number of options, granted Weighted average exercise price, granted Number of options, expired/cancelled Weighted average exercise price, expired/cancelled Number of options, outstanding, ending balance Weighted average exercise price, outstanding, ending balance Number of options, exercisable, ending balance Weighted average exercise price, exercisable, ending balance Weighted average grant date per share fair value, outstanding, beginning balance Weighted average grant date per share fair value, granted Weighted average grant date per share fair value, canceled/expired Number of options, exercised Weighted average exercise price, exercised Weighted average grant date per share fair value, exercised Weighted average grant date per share fair value, outstanding, ending balance Share-Based Payment Arrangement, Option, Exercise Price Range [Table] Share-Based Payment Arrangement, Option, Exercise Price Range [Line Items] Exercisable Price Stock Options Outstanding Stock Options Exercisable Weighted Average Remaining Contractual Life (years) Weighted average contractual life of options exercisable (Years) Weighted average contractual life of options outstanding (years) Number of warrants, outstanding as of the beginning of the periods Weighted average exercise price, outstanding beginning balance Number of warrants, granted Weighted average exercise price, granted Number of warrants, exercised Weighted average exercise price, purchased Number of warrants, outstanding as of the end of the periods Weighted average exercise price, outstanding ending balance Number of warrants, exercisable as of the end of the periods Weighted average grant-date per share fair value outstanding as of the beginning of the periods Weighted average grant-date per share fair value granted Number of warrants, canceled/expired Weighted average exercise price, canceled/expired Weighted average grant-date per share fair value canceled/expired Weighted average exercise price, exercised Weighted average grant-date per share fair value exercised Weighted average grant-date per share fair value outstanding ending balance Class of Warrant or Right [Table] Class of Warrant or Right [Line Items] Exercisable Price Stock Warrants Outstanding Warrants Exercisable Weighted Average Contractual Life of Warrants Outstanding and Exercisable (Years) Schedule of Share-Based Compensation Arrangements by Share-Based Payment Award [Table] Share-Based Compensation Arrangement by Share-Based Payment Award [Line Items] Termination years Stock options outstanding Stock compensation expense Options outstanding, intrinsic value Warrants to purchase common stock Warrant compensation fair value Number of shares issued Granted shares Vested stock option Unrecognized compensation cost Recognized over a remaining weighted-average vesting period Monthly rent payment Stock option granted shares Vesting shares Vesting period Cash Compensation Cash compensation Sponsor fees Payment for sponsor Rent leaving balance Legal proceedings Increase in consideration payable Book Income (Loss) Non-deductible expenses Valuation Allowance Income tax expense Deferred tax assets: NOL carryover R & D credit Depreciation Deferred tax liabilities: Less Valuation Allowance Net deferred tax asset U.S. statutory federal income tax rate Net operating loss carry forwards Income tax expense Option Indexed to Issuer's Equity, Liability [Table] Option Indexed to Issuer's Equity [Line Items] Commmitment amount Equity financing agreement description Aggregate of amount Share price Number of shares issued, value Legal fees Clearing fees Segment Reporting [Table] Segment Reporting [Line Items] REVENUE LESS OPERATING EXPENSES EBITDA SEGMENT NET LOSS Reconciliation of profit or loss Adjustment and reconciling items Number of reportable segments Subsequent Event [Table] Subsequent Event [Line Items] [custom:PreferredStockStatedValue-0] Series C Convertible Preferred Stock [Member] Adjustment to mezzanine. Equity financing cost. Preferred stock stated value. Purchase Agreement [Member] Share based compensation arrangement by share based payment award options outstanding nonvested options exercised weighted average grant date per share fair value. Non-Qualified Stock Options [Member] 35 Months [Member] 36 Months [Member] Schedule of Warrants Acitivity [Table Text Block] Weighted average price at which grantees can acquire the shares reserved for issuance under the stock warrants. Weighted average per share amount at which grantees can acquire shares of common stock by exercise of warrants. Share based compensation arrangement by share based payment award options outstanding non options canceled expired in weighted average grant date per share fair value. Share based compensation arrangement by share based payment award options outstanding non options exercised in weighted average grant date per share fair value. Share based compensation arrangement by share based payment award equity instruments other than options exercised in weighted average grant date per share fair value. Number of warrants, exercisable as of the end of the periods. Warrant One [Member] Increase in consideration payable. Research Agreement [Member] 2022 Incentive Plan [Member] Stock issued during period value issuance of common stock through equity financing. Stock issued during period shares issuance of common stock through equity financing. Equity financing fees. Termination term. Equity Financing Agreement [Text Block] Earnings before interest taxes depreciation and amortization. Issuance of common shares for equity financing. Weighted average price at which option holders acquired shares when converting their stock warrants into shares. The portion of the difference, between total income tax expense or benefit as reported in the Income Statement for the period and the expected income tax expense or benefit computed by applying the domestic federal statutory income tax rates to pretax income from continuing operations, that is attributable to book income. Adjustment and reconciling items. Purchase price of warrants. Equity financing agreement description. Intangible assets amortization expense after year three. Mezzanine [Member] Securities Purchase Agreement [Member] Employee [Member] First Installment 36 Months [Member] First Installment 10 Months [Member] First Installment 22 Months [Member] Exercisable Prices Two [Member] Exercisable Prices Three [Member] Exercisable Prices Four [Member] Exercisable Prices Five [Member] Exercisable Prices Six [Member] Exercisable Prices Seven [Member] December 9 2024 [Member] Exercisable Prices One [Member] Warrant Two [Member] Warrant Three [Member] Warrant Four [Member] Warrant Five [Member] 35 Months Vesting [Member] 36 Months Vesting [Member] GHS Investments LLC [Member] Equity Financing Agreement [Member] Assets, Current Property, Plant, and Equipment, Accumulated Depreciation, Depletion, and Amortization Property, Plant, and Equipment, after Accumulated Depreciation, Depletion, and Amortization Other Assets Assets Liabilities, Current Equity, Attributable to Parent Liabilities and Equity Operating Expenses Other Nonoperating Expense Shares, Outstanding Depreciation, Depletion and Amortization Increase (Decrease) in Prepaid Expense Increase (Decrease) in Other Accounts Payable and Accrued Liabilities Cash Provided by (Used in) Operating Activity, Including Discontinued Operation Cash Provided by (Used in) Financing Activity, Including Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Period Increase (Decrease), Including Exchange Rate Effect and Discontinued Operation Cash, Cash Equivalent, Restricted Cash, and Restricted Cash Equivalent, Including Discontinued Operation AdjustmentToMezzanine Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Outstanding, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Forfeitures and Expirations in Period, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Options, Exercisable, Weighted Average Exercise Price Share-Based Compensation Arrangement by Share-Based Payment Award, Option, Nonvested, Weighted Average Exercise Price ShareBasedCompensationArrangementByShareBasedPaymentAwardNonOptionsOutstandingWeightedAverageExercisePrice Share-Based Compensation Arrangement by Share-Based Payment Award, Equity Instruments Other than Options, Nonvested, Weighted Average Grant Date Fair Value Share-Based Compensation Arrangement by Share-Based Payment Award, Non-Option Equity Instruments, Forfeitures and Expirations ShareBasedCompensationArrangementsByShareBasedPaymentAwardNonOptionsExercisedInPeriodWeightedAverageExercisePrice IncomeTaxReconciliationBookIncome Deferred Income Tax Expense (Benefit) Deferred Tax Assets, Operating Loss Carryforwards Deferred Tax Assets, Net of Valuation Allowance EarningsBeforeInterestTaxesDepreciationAndAmortization